Table 3.
Author | Cancer type | Radiation location | Dose | CTx regimen | Time between RT and gemcitabine start | Time between RT completion and recall symptoms | Clinical symptoms/signs | Undergoing chemo at time of symptom onset? | Imaging findings (and modality) | Treatment | Outcome | Post-treatment CTx? |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Miura et al. [25]a | NSCLC | Lung | 2 Gy × 30 (60 Gy) | Concurrent cisplatin and (80 mg/m2 day 1) and vinorelbine (20 mg/m2, days 1 and 8) followed by vinorelbine (13 mg/m2 biweekly) and gemcitabine (800 mg/m2 biweekly) | 3 months | 5.5 months | Upper chest muscle pain | N/A | Enhancement of pectoralis muscles (MRI) | NSAIDs | Improvement of symptoms | Yes (gefitinib) |
O'Regan et al. [10] | Hodgkin lymphoma | Chest | 1.8 Gy × 22 (39.6 Gy) | 4 cycles of gemcitabine, vinorelbine, and liposomal doxorubicin (unknown dosage) | 2 months | 5 months | Worsening bilateral anterior chest pain, pectoralis muscle necrosis by biopsy | No (last dose 2.5 weeks before presentation) | Diffuse bilateral swelling of the pectoral muscles with mild stranding of the adjacent subcutaneous fat (CT) | Analgesics | Complete resolution | Not reported |
Patel et al. [26] | Nasopharyngeal carcinoma | Head and neck | 70.2 Gy total (fractions N/A) | Gemcitabine (1,000 mg/m2) and oxaliplatin (100 mg/m2) every 2 weeks | N/A (CTx started after RT) | 6 months | Bilateral neck pain and swelling with restriction of neck movement | Yes | Diffuse bilateral soft-tissue edema of the muscles in the cervical neck (MRI) | Dexamethasone | Symptoms worsened with tapering of dexamethasone/low-dose prednisone started without recurrence. | Not reported |
Pinson et al. [27]b | NSCLC | Lung | 3 Gy × 10 (30 Gy) | Carboplatin (AUC 5 on day 1) and gemcitabine (1,000 mg/m2 on days 1 and 8), 3-week cycle | 4 weeks | 14 weeks | Skin erythema, upper chest muscle pain | Yes | Swelling of the pectoralis major and pectoralis minor (CT) | Ibuprofen | Complete resolution in 3 weeks | Not reported |
Squire et al. [14] | NSCLC | Pelvis (left sacroiliac and left acetabulum) | 3 Gy × 10 (30 Gy) | Gemcitabine (1,000 mg/m2) | 1 month | 3 months | Tenderness and discomfort to left hip and buttock, elevated CK | Yes | Edema in gluteal muscles (MRI) | Oral prednisone | Symptoms worsened with tapering of prednisone and improved with increasing doses | Gemcitabine continued for 5 more months, symptoms controlled with prednisone |
Welsh et al. [28] | Bladder cancer | Para-sacral region | 2.5 Gy × 18 (45 Gy) | Gemcitabine and cisplatin (unknown dosage) | 4 weeks | 5 months | Pain in bilateral superolateral gluteal regions | Yes | Band-like pattern of edema on gluteal region (MRI) | NSAIDs, prednisone | Complete resolution after 6 weeks, but with visible residual scar and muscular atrophy | CTx continued |
Current | Breast cancer | Left thigh (femur)/T12 vertebra | 3 Gy × 10 (30 Gy)/24 Gy × 1 (24 Gy) | Gemcitabine (1,000 mg/m2 for days 1 and 8) and herceptin (342 mg every 3 weeks) | 54 days/79 days | 3 months/5.7 months | Worsening leg pain and swelling/Chest and back pain | Yes | Enlargement of muscles of the left thigh (US)/ T12 fracture and paraspinal fluid collections (MRI) | Dexamethasone/T12 vertebroplasty | Progressive resolution of symptoms after 4-month course of dexamethasone/Reduction of chest and back pain following vertebroplasty | Yes (herceptin) |
Paper is written in Japanese.
Paper is written in Dutch.